Navigation Links
Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
Date:2/24/2009

278,019 292,001 -5% Research and development costs, net 11,867 29,429 -60% 86,967 97,957 -11% Acquired in-process research and development 186,300 - - 186,300 - - Restructuring, asset impairments and dispositions 17,001 9,601 77% 21,295 27,675 -23% Amortization expense 12,357 13,438 -8% 49,973 55,985 -11% 335,464 168,922 99% 790,470 631,678 25% Income (loss) from operations (152,450) 20,018 (133,493) 57,825 Interest expense, net (798) (5,864) (13,357) (25,337) Gain (loss) on early extinguishment of debt 3,327 - (11,555) - Other income (expense), net including translation and exchange 5,447 (844) 2,063 1,659 Income (loss) from continuing operations before income taxes and minority interest (144,474) 13,310 (156,342) 34,147 Provision for income taxes 5,974 11,224 39,701 13,535 Minority interest 2 - 7 2 Income (loss) from continuing operations (150,450) 2,086 (196,050) 20,610 Income (loss) from discontinued operations, net (14,798) (22,419) 172,336 (26,796) Net loss $(165,248) $(20,333) $(23,714) $(6,186) Basic earnings (loss) per common share: Income (loss) from continuing operations $(1.82) $0.02 $(2.24) $0.22 Discontinued operations, net (0.18) (0.24) 1.97 (0.29) Net loss $(2.00) $(0.22) $(0.27) $(0.07)
'/>"/>
SOURCE Valeant Pharmaceuticals International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
2. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/28/2014)... that aims to make personalized medicine a reality for ... across British Columbia. , The "Genomics for Precision Drug ... of its kind in North America. The project is ... (BCPhA), with the research component led by a team ... Sciences (UBC). It will position the pharmacist as the ...
(Date:10/27/2014)... elderly people by friends and relatives in the United ... a new RAND Corporation study. , Replacing that care ... $221 billion, while replacing it with skilled nursing ... study, published online by the journal Health Services Research, ... caregiving by making use of the 2011 and 2012 ...
(Date:10/27/2014)... role than previously thought in the opening and closing ... of our cells, researchers at Johns Hopkins report. Those ... concentrations of sodium and calcium ions in cells enables ... The new study reveals that a form of calmodulin ... wide. The finding is likely to bring new insight ...
(Date:10/27/2014)... 27, 2014 The 2014 ... of the world’s top sci­en­tists and inno­va­tors ... fitness via neuroscience-based inno­va­tion. , Indi­vid­u­als ... over $1.3 bil­lion in 2014 in web-based, ... enhance brain func­tion. Growth is poised to ...
(Date:10/27/2014)... EU agency, has gathered information on patients, experiences with ... EudraVigilance. Both authorities and pharmaceutical companies have a duty ... provides new knowledge about unknown and serious ADRs: , ... on asthma medications approved for – and used by ... In the light of the total use of asthma ...
Breaking Medicine News(10 mins):Health News:Genomics helps pharmacists target the right drugs for the right patient 2Health News:Cost of informal caregiving for US elderly is $522 billion annually, study finds 2Health News:200 Experts to Discuss and Shape the Future of Brain Health, Gathered Around a Virtual Table 2Health News:200 Experts to Discuss and Shape the Future of Brain Health, Gathered Around a Virtual Table 3Health News:200 Experts to Discuss and Shape the Future of Brain Health, Gathered Around a Virtual Table 4Health News:Adverse drug reactions in children following use of asthma medications 2
... Calif., April 10, 2008 IPC,The Hospitalist Company, Inc. ... focused on the delivery of hospitalist medicine services,announced today ... 2008,ended March 31, 2008 on Wednesday, May 14, 2008, ... review the results will begin at 5:00 p.m. ET,(2:00 ...
... Partners With Asthma and Allergy Foundation of America To ... Combat Allergens in the Bedroom, ... with the Asthma and Allergy Foundation of America,(AAFA) to educate consumers ... spend one third of their lives: the bedroom., "Many people ...
... Brings Unique Opportunity to Emerging Hip-Hop ... Talent, ... & Gamble,s TAG brand announce the formation of a new,hip-hop record label, TAG ... act as president of the New York-based,venture. As president, Dupri will set the ...
... and OTTAWA, April 10 Natural,Nutrition, Inc. (OTC ... launch its new health and nutritional information portal,iNutrition.com, ... to consumers relating to a healthy lifestyle, nutrition ... as a trusted,healthcare and information resource for our ...
... One Consumer Request, PLANO, Texas, April 10 ... of Pinch of Salt, a,low-sodium version of some of ... chips, Fritos corn chips and Ruffles potato chips.,While Frito-Lay ... with,-- for instance Lay,s Classic potato chips contain 180 ...
... , CamelBak is pleased to announce that our ... by the end of April, 2008. First to,market in ... color, CamelBak will have an entirely BPA-free product line ... Better,Bottle(TM) with Bite Valve, the CamelBak Better Bottle(TM) with ...
Cached Medicine News:Health News:IPC The Hospitalist Company, Inc. to Report First Quarter 2008 Financial Results 2Health News:Leave Bedroom Allergens High and Dry This Spring! 2Health News:Leave Bedroom Allergens High and Dry This Spring! 3Health News:Jermaine Dupri and Island Def Jam Music Group Launch New Hip-Hop Label in Partnership with TAG Body Sprays 2Health News:Jermaine Dupri and Island Def Jam Music Group Launch New Hip-Hop Label in Partnership with TAG Body Sprays 3Health News:Natural Nutrition to Launch iNutrition.com 2Health News:Frito-Lay Launches Low Sodium Versions of its Top Selling Snack Chips 2
(Date:10/30/2014)... 29, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, is committed to pursuing ... developed an innovative, patent-pending dual carrier transdermal delivery ... pharmaceutical active ingredients to penetrate the skin and ... The transdermal delivery method also overcomes microbial drug ...
(Date:10/30/2014)... , Oct. 30, 2014 Today Eli ... details of its long-standing technology transfer program to increase ... Begun in 2003, the effort included Lilly donating manufacturing ... in China , India ... South Africa – all MDR-TB ,hot ...
(Date:10/27/2014)... CHICAGO , Oct. 27, 2014  Demonstrations ... and devices are being featured this week in ... 2014 Scientific Assembly where more than 7,000 emergency ... medicine and participating in educational courses. ... back drop of true-to-life emergency department environments, including ...
Breaking Medicine Technology:ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4Emergency Medicine of the Future Demonstrated at ACEP14 2Emergency Medicine of the Future Demonstrated at ACEP14 3Emergency Medicine of the Future Demonstrated at ACEP14 4Emergency Medicine of the Future Demonstrated at ACEP14 5Emergency Medicine of the Future Demonstrated at ACEP14 6Emergency Medicine of the Future Demonstrated at ACEP14 7Emergency Medicine of the Future Demonstrated at ACEP14 8Emergency Medicine of the Future Demonstrated at ACEP14 9Emergency Medicine of the Future Demonstrated at ACEP14 10Emergency Medicine of the Future Demonstrated at ACEP14 11Emergency Medicine of the Future Demonstrated at ACEP14 12Emergency Medicine of the Future Demonstrated at ACEP14 13Emergency Medicine of the Future Demonstrated at ACEP14 14Emergency Medicine of the Future Demonstrated at ACEP14 15
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: